Patients rehabilitating from stroke represent a large group of people that could potentially benefit from a device like the SurroGait Rx™. The lifetime risk of stroke is 1 in 6. Of the 85% of people who go on to survive their stroke, nearly 10% experience long-term gait disturbance and related rehabilitation needs.
Orpyx hopes to help restore gait function with its SurroGait Rx™ device. The SurroGait Rx™ system transposes plantar pressure to a vibrotactile back pad. The wearer will essentially feel as though they're walking on their back and will be able to use that sensory substitute to alter their behaviour to avoid pressure-induced damage.